This report contains market size and forecasts of Anti-infectious Disease Drugs in global, including the following market information:
- Global Anti-infectious Disease Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Anti-infectious Disease Drugs Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Anti-infectious Disease Drugs companies in 2022 (%)
The global Anti-infectious Disease Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Antibacterial Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-infectious Disease Drugs include Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc. and Advanced Life Sciences Holdings, Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-infectious Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-infectious Disease Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, by Type, 2022 (%)
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
- Antiparasitic Drugs
Global Anti-infectious Disease Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Institute of Medicine
- Clinic
- Others
Global Anti-infectious Disease Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-infectious Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Anti-infectious Disease Drugs revenues share in global market, 2022 (%)
- Key companies Anti-infectious Disease Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Anti-infectious Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Aridis Pharmaceuticals
- AiCuris
- Sandoz
- Anhui Jingfang Medical Industry Co.,Ltd
- Beijing Double-Crane Pharmaceutical Co., Ltd.
- Abbott
- Spero Therapeutics
- Adlyfe, Inc.
- Advanced Life Sciences Holdings, Inc.
- Affinium Pharmaceuticals
- APP Pharmaceuticals
- Aquapharm Biodiscovery
- Basilea Pharmaceutica AG
- Biophage Pharma, Inc.
